Reports on revisions in the American Joint Committee on Cancer's tumor, node metastases (TNM) staging system that affects the staging of two urologic cancers. Revision of prostate and kidney cancer st...
Generally, the higher your Gleason score, the more aggressive the cancer. That means it’s more likely to grow and spread to other parts of your body. Doctors use this information, along with the stage of the cancer, to choose the best treatment for you. The TNM System for Prostate Canc...
total energy intake (as reflected by body mass index) and dietary fat have been incriminated. In addition, there is some evidence that suggests thatobesityleads to an increased risk of having a more aggressive, larger prostate cancer, which results in a poorer outcome after treatment. Nevertheles...
The TNM staging is the most widely used system for prostate cancer staging and assesses the extent of primary tumor (T stage), the absence or presence of regional lymph node involvement (N stage), and the absence or presence of distant metastases (M stage). ...
Stage IV: The cancer has moved farther out to areas like the bones, lymph nodes, liver, or lungs.StageIV, also calledmetastaticor advanced, is considered distant. The three main components doctors use to determine stage are known as TNM: ...
Freedland SJ, Presti JC Jr, Terris MK, Kane CJ, Aronson WJ, Dorey F, Amling CL; The SEARCH Database Study Group (2003b) Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database. J Urol 169:2129...
Prostate Cancer TNM 8 Staging tool. Generate the overall stage of a patient simply and easily using the TNM criteria. Perfect for physicians, surgeons, radiologists, physician assistants, nurses, medical students, trial managers, research and any healthcare professional in the field of oncology. Dev...
Prostate cancer (PCa) is a common malignant tumor with increasing incidence and high heterogeneity among males worldwide. In the era of big data and artificial intelligence, the paradigm of biomarker discovery is shifting from traditional experimental an
Multivariable Relative Risks of Death From Prostate Cancer and Local Progression (Growth Through the Prostate Capsule) in Relation to Follow-up Time, Age at Diagnosis, Tumor Grade, and Tumor Stage* CategoryRelative Risk (95% Confidence Interval)DeathLocal ProgressionFollow-up, y0-41.01.05-92.2 (0....
Higher RAECsig predicts tumor recurrence independent of other clinicopathological parameters, such as the Gleason score and the TNM stage. Many of the 18 RAECsig genes functionally modulate ECs and cancer cells’ proliferation. Our findings suggest that the RAECsig is useful for discriminating patients...